How Ferucarbotran Affects Macrophages
Author Information
Author(s): Yang Chung-Yi, Tai Ming-Fong, Lin Chih-Peng, Lu Chen-Wen, Wang Jaw-Lin, Hsiao Jong-Kai, Liu Hon-Man
Primary Institution: National Taiwan University
Hypothesis
The study investigates the mechanism of cellular uptake of Ferucarbotran in macrophages and its impact on their physiology.
Conclusion
Ferucarbotran is internalized into macrophages via the clathrin-mediated pathway and alters their cellular behavior.
Supporting Evidence
- Ferucarbotran is a clinically approved SPIO-coated carboxydextran used for MRI.
- The study found a dose-dependent uptake of SPIO particles by macrophages.
- Flow cytometry showed a linear correlation between side scattering mean value and iron content.
- Macrophages labeled with SPIO particles showed increased production of reactive oxygen species.
- Ferucarbotran was internalized via the clathrin-mediated pathway.
Takeaway
This study shows that a special type of tiny particles called Ferucarbotran can enter certain immune cells and change how they behave.
Methodology
The study used flow cytometry and spectrophotometry to analyze the uptake of Ferucarbotran by macrophages and assessed changes in their behavior.
Limitations
Ferucarbotran is not currently available on the market, limiting access for further studies.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website